Skip to Content


Active substance(s): TACROLIMUS

PDF options:  View Fullscreen   Download PDF

PDF Transcript

10 mm

10 mm

10 mm

TACNI 0.5mg, 1mg & 5mg HARD CAPSULES
Package leaflet: Information for the user
Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even
if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.

What is in this leaflet
1. What Tacni is and what it is used for
2. What you need to know before you take Tacni
3. How to take Tacni
4. Possible side effects
5. How to store Tacni
6. Contents of the pack and other information


What Tacni is and what it is used for

Tacni is an immunosuppressant. Following your organ transplant (e.g. liver, kidney, heart), your body’s
immune system will try to reject the new organ.
Tacni is used to control your body’s immune response enabling your body to accept the transplanted
Tacni is often used in combination with other medicines that also suppress the immune system.
You may also be given Tacni for an ongoing rejection of your transplanted liver, kidney, heart or other
organ when any previous treatment you were taking was unable to control this immune response after
your transplantation.


What you need to know before you take Tacni

Do not take Tacni
If you are allergic to tacrolimus or any of the other ingredients of this medicine (listed in section 6)
If you are allergic to sirolimus or to any macrolide antibiotic (e.g. erythromycin, clarithromycin,
Warnings and precautions
Talk to your doctor before taking Tacni
- if you are taking any medicines mentioned below under ‘Other medicines and Tacni’ .
- if you have or have had liver problems
- if you have diarrhoea for more than one day
- if you need to receive any vaccinations
Your doctor may need to adjust your dose of Tacni.
You should keep in regular contact with your doctor. From time to time, your doctor may need to do
blood, urine, heart, eye tests, to set the right dose of Tacni.
You should limit your exposure to the sun and UV (ultraviolet) light whilst taking Tacni. This is because
immunosuppressants could increase the risk of skin cancer. Wear appropriate protective clothing and
use a sunscreen with a high sun protection factor.
Other medicines and Tacni
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines
Tacni must not be taken with cyclosporine.
Tacni blood levels can be affected by other medicines you take, and blood levels of other medicines
can be affected by taking Tacni which may require an increase or decrease in dose. In particular, you
should tell your doctor if you are taking or have recently taken medicines like:
antifungal medicines and antibiotics, particularly so-called macrolide antibiotics, used to treat
infections, such as ketoconazole, fluconazole, itraconazole, voriconazole, clotrimazole,
erythromycin, clarithromycin, josamycin, and rifampicin
HIV medicines ( e.g. ritonavir), used to treat HIV infection
medicines for stomach ulcer and acid reflux (e.g. omeprazole, lansoprazole or cimetidine)
antiemetics, used to treat nausea and vomiting (e.g. metoclopramide)
cisapride or the antacid magnesium-aluminium-hydroxide, used to treat heartburn
the contraceptive pill or other hormone treatments with ethinylestradiol, hormone treatments with
medicines used to treat high blood pressure or heart problems (e.g. nifedipine, nicardipine, diltiazem
and verapamil)
medicines known as “statins” used to treat elevated cholesterol and triglycerides
phenytoin or phenobarbital, used to treat epilepsy
the corticosteroids prednisolone and methylprednisolone, belonging to the class of corticosteroids
used to treat inflammations or suppress the immune system (e.g. in transplant rejection)
nefazodone, used to treat depression
Herbal preparations containing St. John’s Wort (Hypericum perforatum) or other herbal preparations.
Tell your doctor if you are taking or need to take ibuprofen, amphotericin B or antivirals (e.g. aciclovir).
These may worsen kidney or nervous system problems when taken together with Tacni.

Your doctor also needs to know if you are taking potassium supplements or certain diuretics used
for heart failure, hypertension and kidney disease, (e.g. amiloride, triamterene, or spironolactone),
non-steroidal anti-inflammatory drugs (NSAIDs, e.g. ibuprofen) used for fever, inflammation and
pain, anticoagulants (blood thinners), or oral medicines for diabetes, while you take Tacni.
If you need vaccinations, tell your doctor in advance that you are taking this medicine.
Tacni with food and drink
Take Tacni on an empty stomach or 2 to 3 hours after a meal. Wait at least 1 hour until the next
meal. Avoid grapefruit (also as juice) while on treatment with Tacni since it can affect its levels.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby,
ask your doctor or pharmacist for advice before taking this medicine.
Tacrolimus passes into breast milk. Therefore you should not breast-feed whilst using Tacni.
Driving and using machines
Tacrolimus may have a minor influence on the ability to drive and use machines. Do not drive or
use any tools or machines if you feel dizzy or sleepy, or have problems seeing clearly after taking
this medicine. These effects are more frequently observed if you also drink alcohol.
Tacni contains lactose
Tacni contains lactose. If you have been told by your doctor that you have an intolerance to some
sugars, contact your doctor before taking this medicine.


How to take Tacni

Always take this medicine exactly as your doctor has told you. Check with your doctor or
pharmacist if you are not sure.
Make sure that you receive the same tacrolimus medicine every time you collect your
prescription, unless your transplant specialist has agreed to change to a different tacrolimus
This medicine should be taken twice a day. If the appearance of this medicine is not the same as
usual, or if dosage instructions have changed, speak to your doctor or pharmacist as soon as
possible to make sure that you have the right medicine.
The starting dose to prevent the rejection of your transplanted organ will be determined by your
doctor calculated according to your body weight. Initial doses just after transplantation will generally
be in the range of 0.075 – 0.30 mg per kg body weight per day depending on the transplanted organ.
Your dose depends on your general condition and on which other immunosuppressive medication
you are taking. Regular blood tests by your doctor will be required to define the correct dose and
to adjust the dose from time to time. Your doctor will usually reduce your tacrolimus capsules dose
once your condition has stabilised. Your doctor will tell you exactly how many capsules to take and
how often.
Tacni is taken orally twice daily, usually in the morning and evening. You should generally take
Tacrolimus capsules on an empty stomach or at least 1 hour before or 2 to 3 hours after the meal.
The capsules should be swallowed whole with a glass of water. Avoid grapefruit and grapefruit
juice while taking Tacrolimus capsules. Do not swallow the desiccant contained in the foil
If you take more Tacni than you should
If you have accidentally taken too much see your doctor or contact your nearest hospital
emergency department immediately.
If you forget to take Tacni
Do not take a double dose to make up for forgotten individual doses.
If you have forgotten to take your capsules, wait until it is time for the next dose, and then continue
as before.
If you stop taking Tacni
Stopping your treatment may increase the risk of rejection of your transplanted organ. Do not stop
your treatment unless your doctor tells you to do so.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tacni reduces your body’s own defence mechanism to stop you rejecting your transplanted organ.
Consequently, your body will not be as good as usual at fighting infections. So if you are taking
Tacni you may therefore catch more infections than usual such as infections of the skin, mouth,
stomach and intestines, lungs and urinary tract.
Severe effects may occur, including allergic and anaphylactic reactions (you may experience: a
sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which
may cause difficulty in swallowing or breathing), and you may feel you are going to faint). It may
be fatal. An uncommon side effect is Haemolytic Uraemic Syndrome, a disease characterised by
acute kidney insufficiency (low urine output /or no urine output), microangiopathic haemolytic
anaemia (decreased number of red blood cells with extreme tiredness, yellowing of the skin or
eyes (jaudince) and a low platelet count with abnormal bruising or bleeding and signs of infection.
It may be fatal. A rare side effect is Thrombotic Thrombocytopenic Purpura (or TTP) which is
characterised by fever and bruising under the skin that may appear as red pinpoint dots, with or
without unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice), with
symptoms of acute renal failure (low urine output/or no urine output). It may be fatal. Benign and
malignant tumours have been reported following treatment as a result of immunosuppression.
10 mm

10 mm

10 mm

10 mm

Possible side effects are listed according to the following categories:
Very common side effects : these may affect more than 1 in 10 patients.
Common side effects : these may affect up to 1 in 10 patients.
Uncommon side effects: these may affect up to 1 in 100 patients.
Rare side effects: these may affect up to 1 in 1000 patients.
Very rare side effects: these may affect up to 1 in 10,000 patients.
Very common side effects: affects more than 1 user in 10

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
By reporting side effects you can help provide more information on the safety of this medicine.


Common side effects: affects up to 1 users in 10
reduction in blood cell counts (platelets, red or white blood cells), increase in white blood cell
counts, changes in red blood cell counts
reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload,
increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood, other
changes in the blood salts (seen in blood tests)
anxiety symptoms, confusion and disorientation, depression, mood changes, nightmare,
hallucination, mental disorders
fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the hands and
feet, dizziness, impaired writing ability, nervous system disorders
blurred vision, increased sensitivity to light, eye disorders
ringing sound in your ears
reduced blood flow in the heart vessels, faster heartbeat
bleeding, partial or complete blocking of blood vessels, reduced blood pressure
shortness in breath, changes in the lung tissue, collection of liquid around the lung, inflammation
of the throat, cough, flu-like symptoms
inflammations or ulcers causing abdominal pain or diarrhoea, bleedings in the stomach,
inflammations or ulcers in the mouth, collection of fluid in the belly, vomiting, abdominal pains,
indigestion, constipation, passing wind, bloating, loose stools, stomach problems
changes in liver enzymes and function, yellowing of the skin due to liver problems, liver tissue
damage and inflammation of the liver
itching, rash, hair loss, acne, increased sweating
pain in joints, limbs or back, muscle cramps
insufficient function of the kidneys, reduced production of urine, impaired or painful urination
general weakness, fever, collection of fluid in your body, pain and discomfort, increase of the
enzyme alkaline phosphatase in your blood, weight gain, feeling feverish
insufficient function of your transplanted organ
Uncommon side effects: affects up to 1 users in 100
changes in blood clotting, reduction in the number of all types of blood cells
dehydration, reduced protein or sugar in the blood, increased phosphate in the blood.
coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language abnormalities,
memory problems
clouding of the eye lens
impaired hearing
irregular heartbeat, stop of heartbeat, reduced performance of your heart, disorder of the heart
muscle, enlargement of the heart muscle, stronger heartbeat, abnormal ECG, heart rate and pulse
blood clot in a vein of a limb, shock
difficulties in breathing, respiratory tract disorders, asthma
obstruction of the gut, increased blood level of the enzyme amylase, reflux of stomach content in
your throat, delayed emptying of the stomach
dermatitis, burning sensation in the sunlight
joint disorders
inability to urinate, painful menstruation and abnormal menstrual bleedings
failure of some organs, influenza like illness, increased sensitivity to heat and cold, feeling of
pressure on your chest, jittery or abnormal feeling, increase of the enzyme lactate
dehydrogenase in your blood, weight loss
Rare side effects: affects up to 1 users in 1000
increased muscle stiffness
collection of fluid around the heart
acute breathlessness
cyst formation in your pancreas
problems with blood flow in the liver
serious illness with blistering of skin, mouth, eyes and genitals, increased hairiness
thirst, fall, feeling of tightness in your chest, decreased mobility, ulcer

How to store Tacni
Keep this medicine out of the sight and reach of children.
Store below 30°C
Store in the original package (within the foil pouch) in order to protect from moisture & light.
Do not use this medicine after the expiry date which is stated on the carton and blister after
{EXP}. The expiry date refers to the last day of that month. Once the foil pouch is opened, the
product should be used within 1 year.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how
to throw away medicines you no longer use. These measures will help protect the environment.

increased blood sugar, diabetes mellitus, increased potassium in the blood
difficulty in sleeping
trembling, headache
increased blood pressure
diarrhoea, nausea
kidney problems


Contents of the pack and other information

What Tacni contains
The active substance is tacrolimus.
For 0.5mg: Each capsule contains 0.5mg of tacrolimus
The other ingredients are:
Capsule content: Povidone K-30, Croscarmellose Sodium (E 468), Lactose anhydrous, Magnesium
Capsule shell: Titanium dioxide (E-171), Yellow Iron Oxide (E-172), Gelatin
For 1 mg: Each capsule contains 1mg of tacrolimus
The other ingredients are:
Capsule content: Povidone K-30, Croscarmellose Sodium (E 468), Lactose anhydrous, Magnesium
Capsule shell: Titanium dioxide (E-171), Gelatin
For 5mg: Each capsule contains 5mg of tacrolimus
The other ingredients are:
Capsule content: Povidone K-30, Croscarmellose Sodium (E 468), Lactose anhydrous, Magnesium
Capsule shell: Titanium dioxide (E-171), Red Iron Oxide (E-172), Gelatin
What Tacni looks like and contents of the pack
Tacni 0.5 mg hard capsules
Ivory cap and ivory body hard shell capsules with white powder.
Tacni 1 mg hard capsules
White cap and white body hard shell capsules with white powder.
Tacni 5 mg hard capsules
Red cap and red body hard shell capsules with white powder.
Tacni hard capsules are supplied as blister strips containing 10 capsules within a protective foil
wrapper, including a desiccant protecting the capsules from moisture. The desiccant should not be
Tacni is available in blister packs of 20, 30, 50, 50x1, 60, 90 and 100 capsules, containing blister strips of
10 capsules each.
Not all pack sizes may be marketed
Marketing Authorization Holder and Manufacturer
TEVA UK Limited,
BN22 9AG.
Laboratorios Cinfa, S.A.
Olaz-Chipi, 10-Políg Areta 31620 Huarte-Pamplona, Navarra,
This leaflet was last revised in July 2015.
PL 00289/1620-22

Very rare side effects: affects up to 1 user in 10,000
muscular weakness
abnormal heart scan
liver failure, narrowing of the bile vessel
painful urination with blood in the urine
increase of fat tissue
Cases of pure red cell aplasia (a very severe reduction in red blood cell counts), agranulocytosis (a
severely lowered number of white blood cells) and haemolytic anaemia (decreased number of red
blood cells due to abnormal breakdown) have been reported.

10 mm

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.